TABLE 3.
(a) List of studies comparing RDP and ODP (b) List of studies comparing RDP and LDP
| Comment | Conversion | P‐value | 90‐day Mortality | P‐value | Morbidity (CD ≥ 3) | P‐value | POPF | P‐value | Operative time | P‐value | Blood loss | P‐value | Spleen preservation | P‐value | R0 ratio | P‐value | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (a) RDP vs ODP | |||||||||||||||||
| Zhou et al 47 | Systematic review | 90‐day | CD ≥ 3 | Grade B C | |||||||||||||
| RDP (n = 515) | NA | ‐ | 0.2% | .030 | 15.2% | .500 | 13.8% | .220 | no difference | .580 | 247 ml less in RDP | <.001 | no difference | .170 | 0.0% | .740 | |
| ODP (n = 1,749) | ‐ | 1.4% | 23.3% | 11.4% | 90.4% | ||||||||||||
| Weng et al 43 ) | PSM for benign to LGM tumor | 90‐day | CD ≥ 3 | Grade B C | |||||||||||||
| RDP (n = 219) | 0.5% | ‐ | 0.5% | 1.00 | 4.1% | 1.00 | 14.6% | .249 | 120 min | <.001 | 50 ml | <.001 | 63.5% | <.001 | 95.4% | .445 | |
| ODP (n = 219) | ‐ | 0.5% | 3.7% | 18.7% | 175 min | 200ml | 26.5% | 97.3% | |||||||||
| (b) RDP vs LDP | |||||||||||||||||
| Kamarajah et al 48 | CD ≥ 3 | Grade B C | |||||||||||||||
| RDP (n = 793) | Systematic review | 8.0% | <.001 | N.A | NA | 12.0% | .78 | 8.0% | .29 | 28 min | <.001 | no difference | .070 | 33.0% | .220 | 95.0% | .970 |
| LDP (n = 2,319) | 21.0% | N.A | 15.0% | 8.0% | shorter in LDP | 21.0% | 89.0% | ||||||||||
| Liu et al 34 * | 90‐day | CD ≥ 3 | Grade B C | * | |||||||||||||
| RDP (n = 102) | PSM | 2.9% | .05 | 0.0% | ‐ | 4.9% | NA | 12.7% | NA | 207 min | .419 | 100 ml | .698 | 95.5% | .001 | NA | NA |
| LDP (n = 102) | 9.8% | 0.0% | 5.9% | 6.9% | 200 min | 100 ml | 52.4% | NA | |||||||||
| De et al 40 | 90‐day | CD ≥ 3 | Grade B C | ||||||||||||||
| RDP (n = 37) | PSM | 13.5% | .53 | 0.0% | ‐ | 10.8% | .308 | 27.0% | .519 | 240 min | .095 | 100 ml | .698 | NA | NA | NA | NA |
| LDP (n = 66) | 15.2% | 0.0% | 6.1% | 28.8% | 230 min | 125 ml | NA | NA | |||||||||
| Qu et al 38 * | 90‐day | CD ≥ 3 | Grade B C | ||||||||||||||
| RDP (n = 35) | PSM for PDAC | 5.7% | .040 | 0.0% | ‐ | 5.7% | NA | 0.0% | NA | 223 min | .3 | 100 ml | .120 | NA | NA | 100% | .310 |
| LDP (n = 35) | 22.9% | 0.0% | 8.6% | 2.9% | 207 min | 200 ml | NA | 97.1% | |||||||||
| Watson et al 48 ) | National data (NCDB) | 90‐day | |||||||||||||||
| RDP (n = 145) | 15.2% | .02 | 0.9% | .077 | NA | NA | NA | NA | NA | NA | NA | N.A | NA | NA | 81.4% | .403 | |
| LDP (n = 660) | 24.4% | 4.7% | NA | NA | NA | NA | NA | 83.5% | |||||||||
| Yang et al 41 | 90‐day | CD ≥ 3 | Grade B C | ||||||||||||||
| RDP (n = 37) | Spleen preservation | 2.7% | .62 | 0.0% | ‐ | 10.8% | .521 | 8.1% | .664 | 313 min | .000 | 201 ml | .443 | 91.9% | .012 | NA | NA |
| LDP (n = 41) | 7.3% | 0.0% | 17.5% | 4.9% | 246 min | 294 ml | 68.3% | NA | |||||||||
Abbreviations: LDP, laparoscopic distal pancreatectomy; LGM, low‐grade malignant; NCDB, National Cancer Database (in the USA); PSM, propensity score matching; RDP, robotic distal pancreatectomy; POPF, postoperative pancreatic fistula.